Advisory Services Network’s Procept Biorobotics PRCT Stock Holding History

Advisory Services Network’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$329K	Sell	14,577 -1,737	-11%	-$43.5K	﹤0.01%	1675
2026 Q1	$408K	Buy	16,314 +894	+6%	+$25.2K	0.01%	1399
2025 Q4	$485K	Sell	15,420 -3,939	-20%	-$131K	0.01%	1232
2025 Q3	$691K	Sell	19,359 -750	-4%	-$34.2K	0.01%	1048
2025 Q2	$975K	Buy	20,109 +250	+1%	+$14.1K	0.02%	835
2025 Q1	$1.16M	Sell	19,859 -1,182	-6%	-$80.7K	0.02%	705
2024 Q4	$1.69M	Buy	21,041 +8,457	+67%	+$723K	0.03%	548
2024 Q3	$769K	Hold	12,584	–	–	0.02%	813
2024 Q2	$769K	Buy	+12,584	New	+$748K	0.02%	813

Other funds holding PRCT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Advisory Services Network's PRCT Position: Q2 2026 in Review

Advisory Services Network reduced its Procept Biorobotics (PRCT) stake by 11% in Q2 2026, selling an estimated $43.5K and leaving 14,577 shares worth $329K. The position accounts for ﹤0.01% of the portfolio, ranked #1675.

Advisory Services Network first reported a position in PRCT in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.69M in Q4 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

Advisory Services Network held 14,577 shares of Procept Biorobotics worth $329K as of Q2 2026.
Advisory Services Network sold 1,737 Procept Biorobotics shares in Q2 2026, an estimated $43.5K.
Procept Biorobotics made up ﹤0.01% of Advisory Services Network's portfolio in Q2 2026, its #1675 holding.
Advisory Services Network first reported a position in Procept Biorobotics in Q2 2024 and has held it in 9 quarters since.
Advisory Services Network's Procept Biorobotics position peaked at $1.69M in Q4 2024.
254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.